Endocrine research remains under threat by the Office of Management and Budget (OMB) proposed rule, Regulation for Federal Financial Assistance. The Society is partnering with national organizations across the United States for a National Day of Action on November 10 to urge Congress to withdraw the proposed rule and we need your help. Please take one minute to join our online advocacy campaign! Our hope is that we can flood the Capitol with messages to influence congressional action.
While the Congress temporarily barred implementation of the proposed rule through December 11, if it does not intervene to permanently block the proposed rule, OMB could finalize the rule as soon as December 12. If finalized, the proposed rule will fundamentally change the grantmaking process for all federal agencies:
If this rule is implemented:
Take action through our campaign to urge Congress to intervene by December 11 and protect and fund endocrine research.
The Society is the leading organization in the diabetes community advocating for Congress to pass two pieces of diabetes legislation before the end of the year and we need your help. The Special Diabetes Program (SDP) is a critical program that funds type 1 diabetes research at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at NIH and type 2 diabetes education and treatment programs for American Indians and Alaska Natives communities. Funding for SDP will expire on December 31 unless Congress acts. The Society is asking Congress to pass a multi-year reauthorization of SDP before the Program expires. We are also urging Congress to pass the INSULIN Act, which is bipartisan legislation that will make insulin more affordable for people living with diabetes. The INSULIN Act would expand the $35 monthly insulin co-pay cap, currently available for Medicare beneficiaries, to the private insurance market. This legislation would also provide resources to help people with diabetes who are uninsured access affordable insulin. Please join our online advocacy campaign urging your Representatives and Senators to reauthorize SDP and pass the INSULIN Act. Taking action is easy and only takes a couple of minutes. Please click here to join our online campaign.
The Endocrine Society continues to support federal research strategies to strengthen research on women’s health across the lifespan, including efforts to improve menopause research and encourage innovative approaches to addressing the health needs of women at midlife. There have been several recent developments in in our advocacy, the National Institutes of Health (NIH), and the White House related to women’s health research:
Endocrine Society Advocacy - The Endocrine Society is leading an effort at the upcoming meeting of the American Medical Association’s (AMA) House of Delegates to pass a resolution supporting women’s health research. We are working closely with the American College of Obstetrics & Gynecology and our colleague organizations in the AMA Endocrine Section Council. Passage of this resolution will influence the agenda of the AMA and its member societies to prioritize women’s health research and will give visibility to the National Strategy to Close the Women’s Health Gap, which calls for Congress to invest $20 billion investment in women’s health research over the next ten years.
NIH - During the recent meeting of the Advisory Council for Research on Women’s Health, Dr. Janine Clayton, Director of the Office of Research on Women's Health (ORWH) described progress NIH has made toward developing common data elements (CDEs) related to menopause. Society members, working through our Research Affairs Core Committee, previously recommended the development of menopause-related CDEs in our response to NIH’s Request for Information on Common Data Elements. We welcome and appreciate ORWH's leadership in moving this work forward and look forward to providing further contributions as NIH improves its data infrastructure supporting menopause research.
ORWH also continues to advance new funding opportunities to spur innovation in women’s health that members of the Endocrine Society may be interested in. The COMpetency in Menopause & Integrate Therapy (COMMIT) Challenge is seeking solutions focused on menopause and provides another avenue for advancing women’s health innovation. Members interested in the opportunity can learn more through the COMMIT Challenge website. Additionally, a RADx Innovation Funnel program focused on midlife women’s health is also being developed. Information about that initiative is available through CIMIT’s Midlife Women’s Health website, with further program details forthcoming.
White House - Last month, the White House released an executive order led by First Lady Melania Trump to advance research and improve care for women and girls throughout every stage of life. The order establishes the White House’s new Women’s Health Task Force and a Women’s Health Division within the NIH.
The Society remains committed to advancing research and encouraging sustained support for evidence-based science that expands knowledge, accelerates new treatments, and ensures women receive the high-quality care they deserve.
We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your US representatives or European Members of Parliament through our online platform. Take action and make a difference today.
